Ethicon Endo-Surgery Holds Metabolic Surgery Scientific Forum Featuring Research By Top ...( CINCINNATI July 28 /- E...),Health

CINCINNATI, July 28 /PRNewswire/ -- Ethicon Endo-Surgery held a scientific symposium at the 26th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) where four leading researchers shared innovative thinking coupled with mounting data about how the biochemical and endocrine effects of metabolic surgery is shaping research, treatment and health care policy for patients battling the co-morbid conditions associated with obesity, particularly Type 2 diabetes.

Moderating the discussion about the biology, mechanisms, and science behind metabolic surgery was Philip Schauer*, MD, Director of the Cleveland Clinic Bariatric and Metabolic Institute. Other participants included:

• Randy J. Seeley*, Ph.D., Professor of Psychiatry and Associate Director of the Metabolic Disease Institute at the University of Cincinnati College of Medicine
• Francesco Rubino*, MD, Chief of Gastrointestinal Metabolic Surgery and Director of the Diabetes Surgery Center at Weill Cornell Medical College-New York Presbyterian Hospital
• Lee M. Kaplan*, MD, Ph.D., Director, Massachusetts General Hospital (MGH) Weight Center and Associate Professor of Medicine at Harvard Medical School
  

"This forum highlights the important role innovative thinking and collaboration play in the fight against obesity - a fight that will require treatment options beyond surgical and pharmaceutical solutions available today to win," said Karen Licitra, Company Group Chairman, Ethicon Endo-Surgery, Inc., who introduced the session. "Ethicon Endo-Surgery is committed to supporting research into the underlying metabolic effect bariatric surgery has on co-morbid conditions, such as Type 2 diabetes, heart disease and cancer. We know bariatric surgery is effective but we don't know how or why. We believe this basic science will help us better understand w
'/>"/>